Preclinical Services

Viroclinics Biosciences works in consultation with clients to understand their development goals and design customized protocols to achieve these. It offers preclinical services to test the efficacy of vaccines, antivirals, antibodies and other products aimed at preventing or treating virus infections. Viroclinics Biosciences uses state of the art BSL-2 and BSL-3 containment facilities enabling it to analyze products for the treatment of normally circulating viruses such as seasonal Influenza and Respiratory Syncytial Virus, but also to emerging viruses that have pandemic potential such as SARS and highly pathogenic avian Influenza.